Skip to main content
Livermore
Livermore
ZHEN

Theseus Pharmaceuticals, Inc.

THRXDelisted Feb 14, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001745020

Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in Theseus Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
−3 vs. Q3 2022
Shares held
33.1M
−541.4K (−1.6%) vs. Q3 2022
Total value
$164.8M
−$30.3M (−15.5%) vs. Q3 2022
New holders
4
20 more added
Sold out
7
10 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 47 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 46 institutionsQ1 2022: 47 institutionsQ2 2022: 51 institutionsQ3 2022: 51 institutionsQ4 2022: 47 institutionsQ1 2023: 72 institutionsQ2 2023: 69 institutionsQ3 2023: 63 institutionsQ4 2023: 70 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $164.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $441.4MQ1 2022: $402.8MQ2 2022: $191.6MQ3 2022: $200.7MQ4 2022: $164.8MQ1 2023: $350.6MQ2 2023: $373.6MQ3 2023: $95.5MQ4 2023: $145.8MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding THRX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$0
Q4 202370$145.8M
Q3 202363$95.5M
Q2 202369$373.6M
Q1 202372$350.6M
Q4 202247$164.8M
Q3 202251$200.7M
Q2 202251$191.6M
Q1 202247$402.8M
Q4 202146$441.4M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q3 2022.

Institutions holding THRX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Credit Suisse AG1$50.00%−93−98.9%Reduced
Citigroup Inc115$5730.00%−142−55.3%Reduced
Legal & General Group Plc1,433$7.14K0.00%00.0%Unchanged
Amalgamated Bank1,901$9.00K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.889$9.78K0.00%00.0%Unchanged
STRS Ohio2,700$13.0K0.00%00.0%Unchanged
Royal Bank of Canada2,917$14.0K0.00%+2,711+1,316.0%Added
UBS Group AG4,644$23.1K0.00%+4,644New
Tower Research Capital LLC (TRC)5,150$26.0K0.00%+730+16.5%Added
California State Teachers Retirement System6,783$33.8K0.00%+76+1.1%Added
American International Group, Inc.8,037$40.0K0.00%−29−0.4%Reduced
Barclays PLC8,904$44.3K0.00%+3,844+76.0%Added
Deutsche Bank AG9,522$47.4K0.00%+112+1.2%Added
New York State Common Retirement Fund9,551$47.6K0.00%00.0%Unchanged
JPMorgan Chase & Co9,639$48.0K0.00%+480+5.2%Added
Morgan Stanley11,478$57.2K0.00%+2,721+31.1%Added
Bank of America Corp14,620$72.8K0.00%+8,725+148.0%Added
Two Sigma Investments, LP17,175$85.5K0.00%+17,175New
Renaissance Technologies LLC18,800$94.0K0.00%+18,800New
Nuveen Asset Management, LLC21,849$109.0K0.00%−14,787−40.4%Reduced
Rhumbline Advisers25,002$125.0K0.00%+154+0.6%Added
Charles Schwab Investment Management Inc43,327$215.8K0.00%00.0%Unchanged
Bank of New York Mellon Corp43,493$216.6K0.00%+349+0.8%Added
Manufacturers Life Insurance Company, The56,068$283.7K0.00%+185+0.3%Added
DAFNA Capital Management LLC81,859$407.7K0.11%−400.0%Reduced
Tekla Capital Management LLC100,000$498.0K0.02%00.0%Unchanged
TD Asset Management Inc106,948$532.6K0.00%00.0%Unchanged
Northern Trust Corp133,301$663.8K0.00%−254−0.2%Reduced
Ensign Peak Advisors, Inc142,598$710.1K0.00%00.0%Unchanged
Laurion Capital Management LP179,619$894.5K0.03%00.0%Unchanged
Walleye Capital LLC198,247$987.3K0.02%+118,849+149.7%Added
Woodline Partners LP234,002$1.17M0.02%−2,388−1.0%Reduced
State Street Corp271,481$1.35M0.00%+23,200+9.3%Added
Geode Capital Management, LLC299,606$1.49M0.00%+12,211+4.2%Added
Boxer Capital, LLC415,000$2.07M0.11%−477,057−53.5%Reduced
Rock Springs Capital Management LP437,329$2.18M0.05%00.0%Unchanged
Opaleye Management Inc.535,000$2.66M0.93%+314,350+142.5%Added
Nextech Invest AG611,310$3.04M1.21%00.0%Unchanged
Vanguard Group Inc638,472$3.18M0.00%+12,529+2.0%Added
Omega Fund Management, LLC711,479$3.54M1.19%00.0%Unchanged
Lynx1 Capital Management LP784,158$3.91M3.38%+279,296+55.3%Added
BlackRock Inc.865,057$4.31M0.00%+89,467+11.5%Added
Price T Rowe Associates Inc1,313,908$6.54M0.00%−67,581−4.9%Reduced
Frazier Life Sciences Management, L.P.1,398,194$6.96M0.43%+1,398,194New
FMR LLC2,498,355$12.4M0.00%−2,304,885−48.0%Reduced
Foresite Capital Management V, LLC3,585,346$17.9M13.87%+250,000+7.5%Added
OrbiMed Advisors LLC17,233,668$85.8M1.64%+192,000+1.1%Added
Farallon Capital Management, L.L.C.0$00.00%−223,149−100.0%Sold out
Wellington Management Group LLP0$00.00%−172,566−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−15,310−100.0%Sold out
Forefront Analytics, LLC0$00.00%−13,065−100.0%Sold out
High Net Worth Advisory Group LLC0$00.00%−800−100.0%Sold out
Wells Fargo & Company0$00.00%−32−100.0%Sold out
Castle Wealth Management LLC0$00.00%−50−100.0%Sold out
Foresite Capital Opportunity Management V, LLC––––Not filed